Identification of Biomarkers in Spinocerebellar Ataxia 3
| Status: | Recruiting |
|---|---|
| Conditions: | Neurology |
| Therapuetic Areas: | Neurology |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 3/23/2019 |
| Start Date: | February 21, 2019 |
| End Date: | December 2021 |
| Contact: | Tasha Kaiser, BS |
| Email: | kaisert@med.umich.edu |
| Phone: | 734-232-6247 |
The purpose of this study is to examine the differences in cerebral spinal fluid (CSF) and
blood of patients with spinocerebellar ataxias and healthy volunteers. The goal of this
project is to identify new biomarkers that are useful for characterizing spinocerebellar
ataxias and identify targets for treatment or prevention of this condition.
blood of patients with spinocerebellar ataxias and healthy volunteers. The goal of this
project is to identify new biomarkers that are useful for characterizing spinocerebellar
ataxias and identify targets for treatment or prevention of this condition.
Inclusion Criteria:
- Confirmed Genetic Testing of SCA3 or Healthy Volunteers
Exclusion Criteria:
- People with unstable thyroid, intestinal/stomach, heart, liver, kidney, blood, lung,
hormones, or other medical or mental disorders at screening Have a tumor or evidence
of having a tumor Women who are pregnant or breast feeding Have a chronic infection or
any severe acute infection within 3 months prior to screening Take anti-coagulants and
NSAIDs Have started any investigational medications in the last month, we must receive
confirmation from the study doctor who prescribed the medicine
We found this trial at
1
site
University of Michigan The University of Michigan was founded in 1817 as one of the...
Click here to add this to my saved trials
